New cancer clinical trial: Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer

Published on: April 24, 2018 at 12:00PM
Condition:   Castration-resistant Prostate Cancer
Intervention:   Drug: Pembrolizumab
Sponsors:   Institute of Cancer Research, United Kingdom;   Merck Sharp & Dohme Corp.
Not yet recruiting
https://ift.tt/2HKpsYb